Biotech

All Articles

Vaccine and Keytruda combo reliable in squamous cell carcinoma

.Immune gate preventions are actually the superheroes of cancer treatment. Medicines like Bristol My...

Cue Biopharma queues up J&ampJ veterinarian as CBO-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of notable management hirings, firings and a...

Regeneron's Opdualag competitor reveals 57% action cost

.Regeneron is actually back with long-lasting follow-up for its LAG-3 prevention and also PD-1 preve...

AstraZeneca messages records on in-house opponents to AbbVie, Pfizer ADCs

.AstraZeneca has shared a very early examine the performance of its internal antibody-drug conjugate...

iTeos- GSK's TIGIT star shows purposeful improvement

.After introducing a period 3 launch based on beneficial midstage outcomes, iTeos as well as GSK are...

More collective FDA may accelerate unusual disease R&ampD: record

.The FDA ought to be a lot more available and also joint to unleash a rise in approvals of unusual d...

Zenas, MBX, Bicara scalp to Nasdaq in hot time for biotech IPOs

.It's an abnormally busy Friday for biotech IPOs, along with Zenas BioPharma, MBX as well as Bicara ...

Atea's COVID antiviral fails to halt hospitalizations in stage 3

.Atea Pharmaceuticals' antiviral has neglected one more COVID-19 trial, but the biotech still stores...

Neurocrine's offer to conserve schizophrenia prospect stops working

.Neurocrine Biosciences' mental illness course pivot has actually stopped working. The biotech was a...

Sanofi spends $110M upfront for late-stage radioligand treatment

.Sanofi has brought in an overdue access to the radioligand event, spending 100 thousand europeans (...